The role of leptin in the regulation of carbohydrate metabolism

Endokrynologia Polska

Volumn 62, Issue 3, 2011, Pages 258-261

  Tucholski, Krzysztof ^a   Otto Buczkowska, Ewa ^a  

^a Child and Mother's Health Centre   (Poland)

Author keywords

Adipose tissue; Diabetes mellitus; Insulin resistance; Insulin secretion; Leptin; Leptin secretion

Indexed keywords

INSULIN; LEPTIN;

ADIPOCYTE; ADIPOSE TISSUE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; DIET RESTRICTION; ENERGY EXPENDITURE; GLUCOSE HOMEOSTASIS; HORMONAL THERAPY; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; METABOLIC REGULATION; PANCREAS ISLET BETA CELL; REVIEW; WEIGHT CONTROL;

ADIPOSE TISSUE, WHITE; ANIMALS; CARBOHYDRATE METABOLISM; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MICE;

EID: 79960818482     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Fujikawa T, Chuang JC, Sakata I et al. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA. 2010; 107: 17391-1736.
2. German JP, Wisse BE, Thaler JP et al. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes 2010; 59: 1626-1634.
3. Kraus D, Herman MA, Kahn BB. Leveraging leptin for type I diabetes? Proc Natl Acad Sci USA 2010; 107: 479-4794.
4. Wang MY, Chen L, Clark GO et al. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci USA 2010; 107: 4813-4819. Comment in: Proc Natl Acad Sci USA 2010; 107: 4793-4794.
5. Jarosz-Chobot P., Otto-Buczkowska E. Zaburzenia hormonalnej regulacji homeostazy glukozy. Hiperglikemia. In: E. Otto-Buczkowska (eds). Endokrynologia wieku rozwojowego - co nowego? Cornetis, Wrocław 2008: 158-182.
6. Otto-Buczkowska E. Leptyna - hormon biora̧ey udział w utrzymaniu homeostazy metabolicznej organizmu. In: E. Otto-Buczkowska (eds). Wybrane zagadnienia patogenezy, diagnostyki i terapii cukrzycy. Borgis, Warszawa 2004: 38-42.
7. Otto-Buczkowska E, Petrulewicz Salamon I. Leptyna i jej rola w cukrzycy. Medycyna Metaboliczna 2004; 8: 59-64.
8. Otto-Buczkowska E. Leptyna - hormon biora̧cy udział w utrzymaniu homeostazy metabolicznej organizmu. In: E. Otto-Buczkowska (eds). Cukrzyca - patogeneza, diagnostyka, leczenie. Borgis, Warszawa 2005: 129-158.
9. Otto-Buczkowska E. Czy leki wspomagaja̧ce znajduja̧ zastosowanie w terapii zaburzeń homeostazy glukozy u młodocianych chorych? In: E. Otto-Buczkowska (eds). Cukrzyca w populacji wieku rozwojowego - co nowego? Cornetis, Wrocław 2009: 180-194.
10. Akther A, Khan KH, Begum M et al Leptin: a mysterious hormone; its physiology and pathophysiology. Mymensingh Med J 2009; 18 (Suppl 1): S140-S144.
11. Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009; 297: E1247-E1259.
12. Sun Q, Cornells MC, Kraft P et al. Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels. Hum Mol Genet 2010; 19: 1846-1855.
13. Ziylan YZ, Baltaci AK, Mogulkoc R. Leptin transport in the central nervous system. Cell Biochem Funct 2009; 27: 63-70.
14. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010; 152: 93-100.
15. Kowalska I, Stra̧czkowski M. Tkanka tłuszczowa jako gruczoł wydzielania wewnȩtrznego. In: E. Otto-Buczkowska (eds). Endokrynologia wieku rozwojowego - co nowego? Cornetis, Wrocław 2008: 92-102.
16. Sousa M, Brás-Silva C, Leite-Moreira A. [The role of leptin in the regulation of energy balance]. Acta Med Port 2009; 22: 291-298.
17. Szalecki M., Janas R. Adipocytokiny - dzialanie metaboliczne i rola w cukrzycy typu 1. In: E. Otto-Buczkowska (eds). Cukrzyca w populacji wieku rozwojowego - co nowego? Cornetis, Wrocław 2009: 69-90.
18. Górska E, Popko K, Winiarska M, Wasik M. Plejotropowe działanie leptyny. Pediatr Endocrinol Diabetes Metab 2009; 15: 45-50.
19. Tudurí E, Marroquí L, Soriano S et al. Inhibitory effects of leptin on pancreatic alpha-cell function. Diabetes 2009; 58: 1616-1624.
20. Antunes H, Santos C, Carvalho S. Serum leptin levels in overweight children and adolescents. Br J Nutr 2009; 101: 1262-1266.
21. Karagüzel G, Ozdem S, Boz A et al. Leptin levels and body composition in children and adolescents with type 1 diabetes. Clin Biochem 2006; 39: 788-793. (Pubitemid 44201187)
22. Schoppen S, Riestra P, García-Anguita A et al. Leptin and adiponectin levels in pubertal children: relationship with anthropometric variables and body composition. Clin Chem Lab Med 2010; 48: 707-711.
23. Silva NY, Tennekoon KH, Senanayake L, Karunanayake EH. Cord blood leptin levels in normal pregnancies, pregnancy induced hypertension and gestational diabetes mellitus. Ceylon Med J 2008; 53: 79-82.
24. Gray SL, Donald C, Jetha A et al. Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling. Endocrinology 2010; 151: 4178-4186.
25. Morioka T, Asilmaz E, Hu J et al Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007; 117: 2860-2868. (Pubitemid 47529616)
26. Hay N. Akt isoforms and glucose homeostasis - the leptin connection. Trends Endocrinol Metab 2011; 22: 66-73.
27. Niswender KD, Magnuson MA. Obesity and the beta cell: lessons from leptin. J Clin Invest 2007; 117: 2753-2756. Comment on: J Clin Invest 2007; 117: 2860-2868.
28. Sun Q, van Dam RM, Meigs JB et al Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes 2010; 59: 611-618.
29. Park S, Hong SM, Sung SR, Jung HK. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Endocrinology 2008; 149: 445-454. (Pubitemid 351159338)
30. Oda N, Imamura S, Fujita T et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008; 57: 268-273.
31. Szadkowska A, Wyka K, Młynarski W et al. Stȩżenie leptyny a insulinowrażliwość u dzieci i młodzieży chorej na cukrzycȩ typu 1. Pediatr Endocrinol Diabetes Metab 2007; 13: 194-200. (Pubitemid 350248136)
32. Szalecki M, Pańkowska E, Wysocka-Mincewicz M et al. Leptyna i rozpuszczalna forma receptora leptyny u dzieci z cukrzyca̧ typu 1. Pediatric Endocrinology, Diabetes and Metabolism 2010; 16: 262-269.
33. Chen WS, Peng XD, Wang Y et al. Leptin deficiency and beta-589*-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol Cell Biol 2009; 29: 3151-3162.
34. Vela-Huerta MM, San Vicente-Santoscoy EU, Guizar-Mendoza JM et al. Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers. J Pediatr Endocrinol Metab 2008; 21: 17-22. (Pubitemid 351350838)
35. Kratzsch J, Knerr I, Galler A et al. Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur J Endocrinol 2006; 155: 609-614. (Pubitemid 44608435)
36. Kitabchi AE, Umpierrez GE. Changes in serum leptin in lean and obese subjects with acute hyperglycemic crises. J Clin Endocrinol Metab 2003; 88: 2593-2596. (Pubitemid 36724429)
37. Kitabchi AE, Umpierrez GE, Fisher JN et al. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab 2008; 93: 1541-1552. (Pubitemid 351656486)
38. Miyanaga F, Ogawa Y, Ebihara K et al. Leptin as an adjunct of insulin therapy in insulin-deficient diabetes. Diabetologia 2003; 46: 1329-1337. (Pubitemid 37297202)
39. Yildiz BO, Haznedaroglu IC. Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol 2006; 38: 820-830. (Pubitemid 43363414)
40. Ramsay TG, White ME. Insulin regulation of leptin expression in streptozotocin diabetic pigs. J Anim Sci 2000; 78: 1497-1503.
41. Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999; 48: 1487-1492. (Pubitemid 29297316)
42. Kojima S, Asakawa A, Amitani H et al. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides 2009; 30: 962-966.
43. Kusakabe T, Tanioka H, Ebihara K et al. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia 2009; 52: 675-683.
44. Chan JL, Wong SL, Orlova C et al. Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay. J Clin Endocrinol Metab 2007; 92: 2307-2311. (Pubitemid 46997138)
45. Park JY, Chong AY, Cochran EK et al. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. J Clin Endocrinol Metab 2008; 93: 26-31.